As global patient populations increase, there are a growing number of challenges and demands faced by pharma and biotech companies to ensure product is delivered in a timely and cost effective way. When capacity is at a premium, significant investment decisions must be made to ultimately determine the expansion of existing facilities, headco unts and technology choices necessary to maintain supply.
With so many elements to consider, a clear strategy must be defined to ensure any potential investment can be maximised for the long term. However this is not always possible due to changes in business objectives and requirements.
An alternative solution to the 'build or buy' decision is the use of readily available, pre-qualified GMP facilities which can be fully tailored to suit individual needs and provide reassurance that product will be delivered on time and on budget.
Engaging with an established CMO to deliver valuable drug product, manufacturing and packaging of all dosage forms offers a range of clear advantages.
The following are just some benefits our clients have experienced thus far.